Protein discovery may explain why patients develop resistance to new anti-cancer drugs

Researchers have identified a protein complex that might explain why some cancer patients treated with the revolutionary new anti-cancer drugs known as PARP inhibitors develop resistance to their medication.

Source: sciencedaily.com